Showing 6611-6620 of 18626 results for "".
Treatment of Hepatic Encephalopathy: When, What, How, and Why?
https://reachmd.com/programs/cme/Treatment-of-Hepatic-Encephalopathy-When-What-How-and-Why/39790/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
https://reachmd.com/programs/cme/clinical-conundrums-in-aria-evolving-approaches-to-mitigate-aria-risk-in-patients-prescribed-anti-a-mabs/27044/Enhance your multidisciplinary approach to ARIA management in Alzheimer's patients with The ARIA Toolkit. Tackle the challenges of ARIA management with concise 5-minute episodes featuring real-world scenarios, practical tips, and expert insights across clinical specialties.Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
https://reachmd.com/programs/cme/clinical-conundrums-in-aria-differential-diagnoses-and-potential-pitfalls-in-aria-evaluation/27042/Enhance your multidisciplinary approach to ARIA management in Alzheimer's patients with The ARIA Toolkit. Tackle the challenges of ARIA management with concise 5-minute episodes featuring real-world scenarios, practical tips, and expert insights across clinical specialties.Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
https://reachmd.com/programs/cme/clinical-conundrums-in-aria-differentiating-and-navigating-aria-vs-stroke-when-an-emergent-mri-is-unavailable/30023/Enhance your multidisciplinary approach to ARIA management in Alzheimer's patients with The ARIA Toolkit. Tackle the challenges of ARIA management with concise 5-minute episodes featuring real-world scenarios, practical tips, and expert insights across clinical specialties.Hepatic Encephalopathy: An Ominous Sign
https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-an-ominous-sign/39278/Learn how PCPs can identify early signs of hepatic encephalopathy to support timely diagnosis and clinical management.Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
https://reachmd.com/programs/cme/patient-perspective-navigating-tgct-treatmentsurgery-vs-systemic-therapy/48911/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Multidisciplinary Collaboration Facilitates Multimodality Therapy
https://reachmd.com/programs/cme/multidisciplinary-collaboration-facilitates-multimodality-therapy/36636/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
https://reachmd.com/clinical-practice/cardiology/analysis-of-patients-with-and-without-af-living-with-hfmrefhfpef-finearts-hf/32984/Dr. Desai discusses new data from ACC 2025 showing that finerenone is effective and safe in patients with HFmrEF/HFpEF, regardless of AF status.Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
https://reachmd.com/clinical-practice/cardiology/mode-of-death-in-patients-with-hfmrefhfpef-the-finearts-hf-trial/32989/Dr. Desai discusses new data from ACC 2025 showing higher proportions of CV and overall mortality in patients with HFmrEF/HFpEF and LVEF ≤50%.Facing Fears About the COVID-19 Vaccines: How to Counsel Patients
https://reachmd.com/programs/covid-19-frontlines/facing-fears-about-the-covid-19-vaccines-how-to-counsel-patients/12307/As the distribution of the COVID-19 vaccine continues to increase, so do the fears of the vaccines’ validity and safety.